Export

Imatinib
Essential medicine status
General description
Imatinib is a BCR-ABL tyrosine kinase inhibitor used in treatment protocols for various leukaemias and solid tumours.
INN
Imatinib
Medicine type
Chemical agent
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Targeted therapies
  • Oral > Solid: 100 mg tablet; 400 mg tablet